Upstream Bio is presenting at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, which highlights the company's commitment to disseminating important research and gaining ...

Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...

Welcome back to The Mining Pod! Today, the gang covers news that Blockspace broke regarding a surprising mixed decision in Crusoe and Upstream Data’s patent dispute. Plus, Lancium gets in on the ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in. On September 30, Upstream Bio presented new structural and mechanistic data for its therapeutic candidate, verekitug, at the ...

Upstream Bio shares rose after the biotechnology company reported positive results for a trial of a sinus-disease treatment. The stock advanced 7.1% to $18.34 on Tuesday. Shares have gained 12% this ...

Upstream Prevention’s Dr. Michaela Rawsthorn will present a free webinar for nonprofit staff on Demystifying Data: A Friendly Introduction to Data Literacy for Nonprofits. The webinar is at noon on ...

Cornerstone Information Systems has launched a new data management platform designed to bring together data from across an increasingly fragmented travel procurement landscape, the company announced.